Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152


Study on biodistribution and radioimmunoimaging of (131)iodine-labeled monoclonal antibody D-D3 against progastrin-releasing peptide31-98 in tumor-bearing mouse.

Liu Z, Zhou X, Shi Y, Du S, Yang Y, Tang J, Shen Y.

Cancer Biother Radiopharm. 2011 Apr;26(2):229-35. doi: 10.1089/cbr.2010.0855. Epub 2011 Apr 21.


[Biodistribution of (99m)Tc-labeled anti-VEGF mAb 5-FU loaded polylactic acid nanoparticles in human gastric carcinoma xenografts].

Huang KH, Liu JH, Zhu ZH, Li XX, Lu XP, Zhou SY.

Nan Fang Yi Ke Da Xue Xue Bao. 2007 Aug;27(8):1137-40. Chinese.


Pre-clinical evaluation of a new indirectly labeled ⁹⁹mTc-6-hydrazinopyridine-3-carboxylic acid (HYNIC)-depreotide with HYNIC as bifunctional chelator.

Yu F, Lü ML, Zhang XP, Fu D, Hou M, Cai HD, Li D, Wang J, Yuan XY, Lü ZW, Dong F.

Chin Med J (Engl). 2012 Jul;125(14):2538-42.


[(99m)Tc radiolabeling of a novel polypeptide molecular probe for lung cancer and its biodistribution in animals].

Li G, Huang B, DU L, Huang K, Liu F, Wang B, Zhang H.

Nan Fang Yi Ke Da Xue Xue Bao. 2013 Aug;33(8):1169-72. Chinese.


99mTc radiotracers based on human GRP(18-27): synthesis and comparative evaluation.

Marsouvanidis PJ, Maina T, Sallegger W, Krenning EP, de Jong M, Nock BA.

J Nucl Med. 2013 Oct;54(10):1797-803. doi: 10.2967/jnumed.112.118695. Epub 2013 Sep 5.


Preparation of (99m)Tc labeled vitamin C (ascorbic acid) and biodistribution in rats.

Yigit US, Lambrecht FY, Unak P, Biber FZ, Medine EI, Cetinkaya B.

Chem Pharm Bull (Tokyo). 2006 Jan;54(1):1-3.


[Preparation of (99m)Tc-EDTA-MN and Its Bioimaging in Mouse].

Qi Y, Li G, Chi X, Du L, Huang K, Zhang H, Huang B.

Zhongguo Fei Ai Za Zhi. 2015 Jul;18(7):422-6. doi: 10.3779/j.issn.1009-3419.2015.07.06. Chinese.


Pretargeting with labeled bivalent peptides allowing the use of four radionuclides: (111)In, (131)I, (99m)Tc, and (188)Re.

van Schaijk FG, Oosterwijk E, Soede AC, Oyen WJ, McBride WJ, Griffiths GL, Goldenberg DM, Corstens FH, Boerman OC.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3880S-5S.


Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.

Santos-Cuevas CL, Ferro-Flores G, Arteaga de Murphy C, Ramírez Fde M, Luna-Gutiérrez MA, Pedraza-López M, García-Becerra R, Ordaz-Rosado D.

Int J Pharm. 2009 Jun 22;375(1-2):75-83. doi: 10.1016/j.ijpharm.2009.04.018. Epub 2009 Apr 22.


Experimental pretargeting studies of cancer with a humanized anti-CEA x murine anti-[In-DTPA] bispecific antibody construct and a (99m)Tc-/(188)Re-labeled peptide.

Karacay H, McBride WJ, Griffiths GL, Sharkey RM, Barbet J, Hansen HJ, Goldenberg DM.

Bioconjug Chem. 2000 Nov-Dec;11(6):842-54.


Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CT.

Gainkam LO, Huang L, Caveliers V, Keyaerts M, Hernot S, Vaneycken I, Vanhove C, Revets H, De Baetselier P, Lahoutte T.

J Nucl Med. 2008 May;49(5):788-95. doi: 10.2967/jnumed.107.048538. Epub 2008 Apr 15.


[IgG radiolabelling with (99m)Tc by tricarbonyl method and its biodistribution in mice].

Chi XH, Huang BD, Wang B, Huang K, Li GP.

Nan Fang Yi Ke Da Xue Xue Bao. 2010 Dec;30(12):2643-5. Chinese.


(99m)technetium-HYNIC(tricine/TPPTS)-Aca-bombesin(7-14) as a targeted imaging agent with microSPECT in a PC-3 prostate cancer xenograft model.

Ananias HJ, Yu Z, Dierckx RA, van der Wiele C, Helfrich W, Wang F, Yan Y, Chen X, de Jong IJ, Elsinga PH.

Mol Pharm. 2011 Aug 1;8(4):1165-73. doi: 10.1021/mp200014h. Epub 2011 Jun 30.


(99m)Tc-labeled murine ior C5 monoclonal antibody in colorectal carcinoma patients: pharmacokinetics, biodistribution, absorbed radiation doses to normal organs and tissues and tumor localization.

Iznaga-Escobar N, Ramos-Suzarte M, Morales-Morales A, Torres-Arocha L, Rodríguez-Mesa N, Pérez-Rodriguez R.

Methods Find Exp Clin Pharmacol. 2004 Nov;26(9):687-96.


Biodistribution characteristics and SPECT imaging of (99m)Tc-RET and (99m)Tc-REG in human lung cancer xenografts.

Xie WH, Zhang B, Wang LH, Liu CY, Chang C, Lei B, Wu YW.

Cancer Biother Radiopharm. 2015 Apr;30(3):117-24. doi: 10.1089/cbr.2014.1765. Epub 2015 Feb 25.


Effects of the antifolates pemetrexed and CB3717 on the tissue distribution of (99m)Tc-EC20 in xenografted and syngeneic tumor-bearing mice.

Müller C, Reddy JA, Leamon CP, Schibli R.

Mol Pharm. 2010 Apr 5;7(2):597-604. doi: 10.1021/mp900296k.


Preparation and Evaluation of (99m)Tc-Epidermal Growth Factor Receptor (EGFR)-Peptide Nucleic Acid for Visualization of EGFR Messenger RNA Expression in Malignant Tumors.

Zhao X, Wang N, Ren X, Zhang J, Wang J, Han J, Jia L, Liu Y, Zhang Z.

J Nucl Med. 2014 Jun;55(6):1008-16. doi: 10.2967/jnumed.113.136101. Epub 2014 Apr 17.


[Radio-labeling of T7 peptide with 99mTc and its biodistribution in nude mice bearing non-small cell lung cancer].

Hao Y, He X, Zhou X, Meng A, Liu J, Liu J, Song N.

Zhongguo Fei Ai Za Zhi. 2014 Mar;17(3):189-96. doi: 10.3779/j.issn.1009-3419.2014.03.02. Chinese.

Supplemental Content

Support Center